Phase 1b clinical site start-up and regulatory activities in Australia underway to support the global registrational program -HUNTSVILLE, AL, ...
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...
A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...
The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS and Parkinson's.
About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the ...
A loss of the sense of smell or acting out one’s dreams can occur years in advance.
The researchers found an unknown interaction in the brain and was able to target it.
Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to treat Parkinson's disease. The new study, published in the journal Movement ...
Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...
Ask any smoker who has tried to quit and they’ll tell you it isn’t easy. But a recent study offers a surprising glimmer of hope – one that may already be sitting on pharmacy shelves. A team of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results